Effect of ketanserin on central haemodynamics and coronary circulation

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 6, 1998, Pages 983-987

  Hood, S ^a,b   Birnie, D ^a   Nasser, A ^a   Hillis, W S ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Coronary arteries; Ketanserin; Pulmonary circulation; Vasodilatation

Indexed keywords

KETANSERIN; SEROTONIN 2 ANTAGONIST;

ADULT; ANGINA PECTORIS; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DRUG MECHANISM; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CIRCULATION; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA PECTORIS; BLOOD PRESSURE; CARDIAC OUTPUT; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KETANSERIN; MALE; MIDDLE AGED; PULMONARY CIRCULATION; PULMONARY WEDGE PRESSURE; SEROTONIN ANTAGONISTS; VASCULAR RESISTANCE;

EID: 0031675574     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199812000-00016     Document Type: Article

References (20)

1. Willerson JT, Golino P, Eidt J, Campbell WH, Bula LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation 1989;80:198-205.
2. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981;304:685-91.
3. van den Berg EK, Schmits JM, Benedict CR, Malloy CR, Wilierson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 1989;79:116-24.
4. Rubanyl GM, Frye RL, Holmes DR Jr, Vanhoutte PM. Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease. J Am Coll Cardiol 1987;9:1243-9.
5. 2-receptor activation. Eur J Pharmacol 1989;161:91-4.
6. Chester AH, Martin GR, Bodelsson M, et al. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res 1990;24:932-7.
7. Golino P, Piscione F, Willerson JT, et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991;324:641-8.
8. Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med 1994;330:523-8.
9. Tousoulis D, Davies G, Tentolouris C, Apostolopoulos T, Kyriakides M, Toutouzas P. Effects of ketanserin on epicardial coronary arteries after coronary angioplasty in patients with stable angina. Eur Heart J 1994;15:922-7.
10. Hosie J, Stott DJ, Robertson JIS, Ball SG. Does acute serotonergic type 2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension. J Cardiovasc Pharmacol 1987;10(suppl 3):S86-8.
11. Woittiez AJJ, Wenting GJ, Manint Veld AJ, Boomsma F, Schalekamp MADH. Ketanserin: a possible tool for studying the role of serotonin in hypertension. J Cardiovasc Pharmacol 1985;7(suppl 7):S130-3.
12. Marwood JF, Stokes GS. Vascular smooth muscle, serotonin and alpha adrenoceptor. Clin Exp Pharmacol Physiol 1983;10:265-7.
13. Van Neuten JM, Schurkes JAJ, De Ridder WJE, Kuyps JJMD, Janssens WJ. Comparative pharmacological profile of ritanserin and ketanserin. Drug Dev Res 1986;8:187-95.
14. Woittiez AJJ, Wenting GJ, van den Meiracker AH, et al. Chronic effect of ketanserin in mild to moderate essential hypertension. Hypertension 1986;8:167-73.
15. Vandenbroucke G, Foubert L, Coddens J, Deloof T, Evenepoel MC. Use of ketanserin in the treatment of hypertension following coronary artery surgery. J Cardiothorac Vasc Anaesth 1994;8:324-9.
16. Richter JA, Barankay A, Gob E, Spath P. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery. J Cardiovasc Pharmacol 1986;8:109-15.
17. Van der Starre PJ, Harinck-de-Weerd JE, Reneman RS. Nitroprusside and ketanserin in the treatment of post-operative hypertension following coronary artery bypass grafting: a haemodynamic and ventilatory comparison. J Hypertens Suppl 1986;4:S107-10.
18. 1Dβ receptors. Circulation 1994;90:1141-53.
19. Martin GR, Leff P, Canbridge D, Barren VJ. Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedebergs Arch Pharmacol 1987;336:365-73.
20. Leff P, Martin GR, Morse JM. Differential classification of vascular smooth muscle and endothelial cell 5HT receptors by use of tryptamine analogues. Br J Pharmacol 1987;91:321-31.